: iStockAnalyst.com Symbols Feed

Insider Buys And Sells: Weekly Wrap-up

Mon, 02 Nov 2009 19:39:37 GMT

For all the analysts and pundits in the financial media, there is still no better judge of a company's health and future prospects than the owners and executives of those companies themselves, along with major institutional shareholders.[More...]

Seven Potential Short Stocks In Healthcare

Mon, 26 Oct 2009 13:45:00 GMT

On October 12, I wrote an article on seven bull stocks to know in healthcare (medical) sector. In the present article, I will be taking you through the seven stocks that you could profit by shorting.[More...]

Speedus Corp. (Nasdaq: SPDE): Is This The Next Hot Medical Technology Stock?

Fri, 18 Sep 2009 03:50:45 GMT

Bought 3000 Speedus Corp (SPDE) at $7.35ish….the stock is up 100%+ today on FDA approval for their interesting heart and lung scanner that can transmit data over the internet to specialist, cool sounding, but more importantly, they already sold a couple of these to the army,[More...]

Intuitive Surgical Profit Surprises

Thu, 23 Jul 2009 16:45:08 GMT

Intuitive Surgical (ISRG) recorded 19% revenue growth and 22% net income growth in the second quarter – defying the reduced capital spending by hospitals in the U.S. Revenues increased to $260.6 million from $219.2 million a year ago. Gross margin expanded to 73.0% from 71.2%. Net income was $62.4 million, or $1.62 per diluted share compared to $51.2 million, or $1.28 per diluted share during the year-ago period.? Revenues include $13.8 million of revenue deferral. Last quarter, Intuitive Surgical had deferred a total of $20.1 million of revenues – related to discount offers made to some of its clients for upgrading da Vinci S surgical systems to recently launched da Vinci Si surgical systems. The company expects to record the balance $6.3 million during the second[More...]

Intuitive Surgical (NASDAQ: ISRG): Second Quarter Earnings Preview 2009

Wed, 22 Jul 2009 17:55:40 GMT

Intuitive Surgical Inc. is scheduled to post its second-quarter results after the market closes on Wednesday. Analysts currently expect the company to report net profit of $48.5 million on revenue of $229.5 million.[More...]

S&P 500 Stocks With Highest Short Interest

Mon, 13 Jul 2009 15:48:17 GMT

Going into earnings season it is always interesting to see which stocks have the highest short interest. The reason for that is if there are any "surprises" to the upside, these tend to be the stocks that take off like a rocket as shorts are forced to cover (buy). Courtesy of Bespoke blog we have an interesting list below - including many names we discuss, cover, or have shorted from time to time! (click to enlarge) [More...]

Paired Trade: Buy Hormel, Sell DineEquity

Fri, 10 Jul 2009 00:09:39 GMT

This is the 7th in a series of ideas where I contrast a cheap security with an expensive one that otherwise shares some characteristics. So far, I am 5 for 6: [More...]

Bret Barakett's Tremblant Capital Group Bets On Technology: 13F Filing Q1 2009

Wed, 10 Jun 2009 16:15:00 GMT

This is the 1st Quarter 2009 edition of our ongoing hedge fund portfolio tracking series. Before reading this update, make sure you check out the Hedge Fund 13F filings series preface. Next up, we have Tremblant Capital Group. Tremblant is a $3 billion hedge fund based in New York and is run by Bret Barakett, who is a former portfolio manager at Moore Capital Management (the hedge fund run by the great Louis Bacon, whom we also track). If the last name of 'Barakett' sounds familiar, its because his brother, Timothy Barakett, manages fellow hedge fund Atticus Capital, whose portfolio we recently covered. Taken from their site, Tremblant Capital Group's objective is "to achieve superior risk adjust returns[More...]

Intuitive Surgical (NasdaqGS: ISRG): Beating Hearts And Outperforming

Mon, 18 May 2009 16:09:10 GMT

High-beta stocks have started to gain favor with investors after getting demolished during the vicious bear market that took the S&P 500 down to 666.[More...]

Novadaq Q1 Net Loss Narrows

Thu, 14 May 2009 07:52:00 GMT

Novadaq Technologies, a Canada-based developer of real-time medical imaging systems for the operating room, has reported a net loss of $2.47 million, or $0.10 per share, for the first quarter of 2009, compared to a net loss of $4.84 million, or $0.20 per share, for the first quarter of 2008.
This was driven by year-over-year total revenue increases in SPY capital sales and SPY recurring revenues.
Largely as a result of the company's product mix continuing to move toward the higher margin SPY product set, the gross margin percentage increased to 55% in the first quarter of 2009 compared to 47% in the first quarter of 2008.

: iStockAnalyst.com Symbols Feed

Insider Buys And Sells: Weekly Wrap-up

Seven Potential Short Stocks In Healthcare

Speedus Corp. (Nasdaq: SPDE): Is This The Next Hot Medical Technology Stock?

Intuitive Surgical Profit Surprises

Intuitive Surgical (NASDAQ: ISRG): Second Quarter Earnings Preview 2009

S&P 500 Stocks With Highest Short Interest

Paired Trade: Buy Hormel, Sell DineEquity

Bret Barakett's Tremblant Capital Group Bets On Technology: 13F Filing Q1 2009

Intuitive Surgical (NasdaqGS: ISRG): Beating Hearts And Outperforming

Novadaq Q1 Net Loss Narrows

Intuitive Surgical to Repurchase $150 million Common Stock from Goldman

Chindex International, Inc. To Participate in UBS Global Healthcare Services Conference

'09 Blade Stock Market Entries Favor Familiar Names

Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference

The Flintstones Meet the High-Tech Future

Movers: Costco, Yahoo, WaMu, Boeing, EMC, VMware

Chindex International, Inc. Announces New CDC Contract ; German KfW Development Bank-Financed Project Will Bring EUR5 Million in Revenue

Novadaq Reports Second Quarter 2009 Financial Results

Power Medical Interventions(R) Reports Second Quarter 2009 Financial Results; PMI to Be Acquired By Covidien

Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results ; 1Q 2010 Revenue Increases 41% Year Over Year to $45.3 Million; 1Q 2010 Net Income Increases Year Over Year to $3.3 Million, or $0.20 Per Diluted Share

Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products ; New Product Agreements Complement and Further Enhance Medical Product Offering

Intuitive Surgical Announces Second Quarter Earnings

Affymetrix Reports Second Quarter 2009 Results ; -- Company Reports Total Revenue of $81.6 Million and Net Income of $7.3 Million --

Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

Intuitive Surgical, Inc. Second Quarter, 2009 Earnings Conference Call

International Datacasting Corporation's 3D Products With Sensio(R) Technology Part of Surgical Demo in South Korea

Form 4 MCNAMARA JEROME J For: Nov 05 (10K)

Form 4 INTUITIVE SURGICAL INC For: Nov 05 Filed by: MOHR MARSHALL (10K)

Form 4 INTUITIVE SURGICAL INC For: Oct 26 Filed by: SMITH LONNIE M (10K)

Form 4 DUGGAN ROBERT W For: Aug 04 (10K)

Form 4 MCNAMARA JEROME J For: Aug 20 (10K)

Form 4 MCNAMARA JEROME J For: Jul 28 (10K)

Form 4 HALVORSON ERIC H For: Jul 27 (10K)

Form 4 INTUITIVE SURGICAL INC For: Mar 11 Filed by: SMITH LONNIE M (10K)

Form 4 INTUITIVE SURGICAL INC For: Jul 27 Filed by: MOHR MARSHALL (10K)

Form 4 KRAMER RICHARD J For: Jul 16 (10K)